Zhengye Biotechnology Holding LimitedZhengye Biotechnology Holding LimitedZhengye Biotechnology Holding Limited

Zhengye Biotechnology Holding Limited

No trades
See on Supercharts
Market capitalization
‪212.25 M‬USD
0.06USD
‪4.44 M‬USD
‪29.87 M‬USD
Beta (1Y)
Employees (FY)
275
Change (1Y)
−19 −6.46%
Revenue / Employee (1Y)
‪108.63 K‬USD
Net income / Employee (1Y)
‪16.15 K‬USD

About Zhengye Biotechnology Holding Limited


CEO
Song Lin Song
Headquarters
Jilin City
Founded
2023
FIGI
BBG01KY0HFQ6
Zhengye Biotechnology Holding Ltd. engages in the manufacture and sale of veterinary vaccines. It offers a range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The company was founded on March 24, 2023 and is headquartered in Jilin City, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ZYBT is 4.50 USD — it has decreased by −7.41% in the past 24 hours. Watch Zhengye Biotechnology Holding Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Zhengye Biotechnology Holding Limited stocks are traded under the ticker ZYBT.
ZYBT stock has risen by 19.36% compared to the previous week, the month change is a 19.36% rise, over the last year Zhengye Biotechnology Holding Limited has showed a 19.36% increase.
Yes, you can track Zhengye Biotechnology Holding Limited financials in yearly and quarterly reports right on TradingView.
ZYBT net income for the last half-year is ‪1.25 M‬ USD, while the previous report showed ‪1.56 M‬ USD of net income which accounts for −19.84% change. Track more Zhengye Biotechnology Holding Limited financial stats to get the full picture.
No, ZYBT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jan 10, 2025, the company has 275.00 employees. See our rating of the largest employees — is Zhengye Biotechnology Holding Limited on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Zhengye Biotechnology Holding Limited EBITDA is ‪8.14 M‬ USD, and current EBITDA margin is 37.18%. See more stats in Zhengye Biotechnology Holding Limited financial statements.
Like other stocks, ZYBT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Zhengye Biotechnology Holding Limited stock right from TradingView charts — choose your broker and connect to your account.